PDCD1 and neoplasm: One aspect that is going to be investigated is the lack of PD-1/PD-L1 expression in certain subgroups of EC patients, which is a critical mechanism for immune evasion by tumor cells with deep genetic mutations, epigenetic alterations, or microenvironmental factors.